Mitchell Chan
Chief Financial Officer at REGENXBIO Inc. (RGNX) since September 2024
Mitchell Chan has filed 17 insider reports with the SEC since March 2021, as chief Financial Officer at REGENXBIO Inc. (RGNX), director at Avalo Therapeutics, Inc. (AVTX) and officer at Viela Bio, Inc. (VIE). In the last 12 months Mitchell Chan sold $72.5K of stock on the open market. The latest filing, on November 3, 2026, reports grant or award at REGENXBIO Inc. (RGNX).
- Filings
- 17
- Companies
- 3
- Bought on market
- None
- Sold on market
- $72.5K
Companies where Mitchell Chan is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Chief Financial Officersince September 2024 | 147,120 | $7.64 | Nov 3, 2026 | ||||
| Directorsince December 2021 | 3,166 | $72.5K | $7.76 | May 7, 2026 | |||
| Officer | 0 | Mar 15, 2021 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Nov 1, 2026RGNXChief Financial Officer Chan Mitchell was granted 24,305 shares, increasing direct ownership by 20% to 147,120 unitsForm 4Grant or award
- Sep 1, 2026RGNXChief Financial Officer Chan Mitchell covered exercise/tax liability with 4,902 shares, decreasing direct ownership by 4% to 122,815 unitsForm 4Shares withheld for taxes or exercise price
- May 6, 2026-$72.5KAVTXDirector Chan Mitchell sold $72,461 worth of shares (3,167 units at $22.88) as part of a pre-agreed trading plan, decreasing direct ownership by 50% to 3,166 unitsForm 4Open-market sale10b5-1 plan
- Mar 28, 2026AVTXSEC Form 4 filed by Chan MitchellForm 4Exercise or conversion of a derivative
- Jan 6, 2026RGNXChief Financial Officer Chan Mitchell was granted 73,749 shares, increasing direct ownership by 137% to 127,717 unitsForm 4Grant or award
- Sep 1, 2025RGNXChief Financial Officer Chan Mitchell covered exercise/tax liability with 4,901 shares, decreasing direct ownership by 8% to 53,968 unitsForm 4Shares withheld for taxes or exercise price
- Jun 17, 2025AVTXSEC Form 4 filed by Director Chan MitchellForm 4Grant or award
- Mar 28, 2025AVTXDirector Chan Mitchell converted options into 3,167 sharesForm 4Exercise or conversion of a derivative
- Jan 2, 2025RGNXSEC Form 4 filed by Chief Financial Officer Chan MitchellForm 4Grant or award
- Sep 16, 2024RGNXChief Financial Officer Chan Mitchell was granted 58,869 sharesForm 4Grant or award
- Sep 16, 2024RGNXMitchell Chan became an insiderForm 3New insider
- Aug 13, 2024AVTXSEC Form 4 filed by Director Chan MitchellForm 4Grant or award
- Dec 20, 2023AVTXSEC Form 4 filed by Chan MitchellForm 4Grant or award
- Jun 14, 2022AVTXSEC Form 4 filed by Chan MitchellForm 4Grant or award
- Dec 1, 2021AVTXSEC Form 4 filed by Chan MitchellForm 4Grant or award
- Dec 1, 2021AVTXMitchell Chan became an insiderForm 3New insider
- Mar 15, 2021VIESEC Form 4: Mitchell Chan disposed to the issuer $1,987,500 worth of Common Stock (37,500 units at $53.00), decreasing direct ownership by 100% to 0 unitsForm 4Sale back to the company
Compare Mitchell Chan with
- Mitchell Chan vs Craig Malzahn1 shared
- Mitchell Chan vs Patrick J. Christmas1 shared
- Mitchell Chan vs Steve Pakola1 shared
- Mitchell Chan vs Kevin Robert Lind1 shared
- Mitchell Chan vs Rita Jain1 shared
- Mitchell Chan vs Ron M Philip1 shared
Other insiders at the same companies
- Craig MalzahnRGNX
- Patrick J. ChristmasRGNX
- Steve PakolaRGNX
- Rita JainAVTX
- Kevin Robert LindAVTX
- Ron M PhilipAVTX
- Christopher Ryan SullivanAVTX
- Mittie DoyleAVTX
- Gregory Austin CiongoliRGNX
- Jennifer RileyAVTX
- Curran SimpsonRGNX
- Paul VarkiAVTX
- Samantha TruexAVTX
- Gilla KaplanAVTX
- Aaron KantoffAVTX
- Michael Thomas HeffernanAVTX
Questions about Mitchell Chan
- What is Mitchell Chan's role at REGENXBIO Inc.?
- Mitchell Chan reports to the SEC as chief Financial Officer at REGENXBIO Inc. (RGNX), according to the latest filing on November 3, 2026. Mitchell Chan has also filed as director at Avalo Therapeutics, Inc. (AVTX) and officer at Viela Bio, Inc. (VIE).
- How many shares does Mitchell Chan own?
- After the latest filing that states it, Mitchell Chan directly owned 147,120 shares of REGENXBIO Inc. (RGNX) and 3,166 shares of Avalo Therapeutics, Inc. (AVTX). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Mitchell Chan bought or sold stock recently?
- The most recent open-market sale was on May 6, 2026: sold 3,167 shares of Avalo Therapeutics, Inc. (AVTX) for $72.5K at an average of $22.88.
- How do I get alerts when Mitchell Chan files?
- Follow Mitchell Chan on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. Mitchell Chan filed 2 times in the last 90 days.
From SEC Forms 3, 4, 5 and 144 filed by Mitchell Chan (SEC CIK 0001789335). Totals count each trade once, skipping amendments whose original is on file, from Mar 15, 2021 on. View on SEC EDGAR